Frontiers in Asthma Research: Mechanisms and Pathways
Wednesday, January 13th, 8.00 a.m. – 5.00 p.m.

Co-chaired by:

•  K. Frank Austen M.D., Brigham and Women’s Hospital, Professor, Harvard Medical School and
• Andrew Luster M.D. Ph.D., Massachusetts General Hospital, Professor, Harvard Medical School

Speakers include:

• Steve Holgate (U Southampton, UK) “Understanding the gaps & needs in therapeutic treatments for asthma with respect to current clinical practice, Lessons from biologics and genetics”
• Bill Busse (U Wisconsin)  “What does success with targeted therapies within subgroups tell us about different mechanisms of asthma?” 
• Bart Lambrecht (U Ghent, Belgium) “Dendritic cells in the lung and adjuvant properties of allergens”
• Yong Jun Liu (U Texas) “New cytokine pathways (TSLP, IL-25, IL-33)”
• Gary O'Neill (MRL Boston) ” Experience with the development of DP1: Lessons”
   Marsha Wills-Karp  (Cincinnati Med Center)  ”Epithelium as an active participant in responding to allergens awaiting response”
• David Artis (U Pennsylvania) “Basophils as key APCs in Th2 responses”
• Dan Cua (MRL, Palo Alto) "The IL-17 pathway and Implications for Asthma"
• Catherine Hawrylowitz (Kings College London, UK) “Regulatory T Cells in Asthma”

Note: Under Massachusetts law, a pharmaceutical manufacturing company may not provide or pay for a meal to a Health Care Practitioner outside of the office or hospital setting.
» All Health Care Providers please read this important material before registering